William Sharfman Selected Research

Antibodies

1/2017

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William Sharfman Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 03/2024 - 06/2005
10	Neoplasms (Cancer) 03/2024 - 03/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2021
1	Dermatitis 03/2024
1	Fatigue 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 03/2024
1	Infections 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Colitis 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Sinusitis 10/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Headache (Headaches) 01/2017
1	Disease Progression 06/2005

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2017
6	NivolumabIBA 03/2024 - 01/2017
5	IpilimumabIBA 01/2021 - 10/2013
2	Monoclonal AntibodiesIBA 03/2024 - 03/2010
2	InterferonsIBA 01/2021 - 10/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2018
1	Cetuximab (Erbitux)FDA Link 03/2024
1	urelumabIBA 03/2024
1	tofacitinibIBA 01/2021
1	CarcinogensIBA 01/2021
1	trametinibIBA 01/2018
1	dabrafenibIBA 01/2018
1	Lactate Dehydrogenase 5IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	raf KinasesIBA 08/2017
1	RAF265IBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	AntibodiesIBA 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Interleukin-2 (IL2)IBA 10/2013
1	Immunoglobulin G (IgG)IBA 03/2010
1	Integrin beta3 (GPIIIa)IBA 03/2010
1	etaracizumabIBA 03/2010
1	Dacarbazine (DIC)FDA LinkGeneric 03/2010
1	Integrin alphaVbeta3IBA 03/2010
1	Bortezomib (Velcade)FDA Link 06/2005
1	Proteasome InhibitorsIBA 06/2005

Therapy/Procedure

8	Therapeutics 03/2024 - 01/2017
3	Immunotherapy 03/2024 - 10/2013
1	Neoadjuvant Therapy 01/2021
1	Radiotherapy 01/2018